Cebrino Jesús, Portero de la Cruz Silvia
Department of Preventive Medicine and Public Health, University of Seville, Seville, Spain.
Department of Nursing, Pharmacology and Physiotherapy, University of Córdoba, Córdoba, Spain.
Front Pharmacol. 2023 Apr 21;14:1189644. doi: 10.3389/fphar.2023.1189644. eCollection 2023.
Few studies have examined the epidemiology of polypharmacy in non-institutionalized elderly adults with regard to sex differences. This study aimed to identify the prevalence of polypharmacy among people ≥65 years old residing in Spain, analyze trends in that prevalence from 2011/12 to 2020, describe the use of the medicines involved and study the possible relationship between polypharmacy and certain sociodemographic, health-related variables, as well as the use of care services by sex. A nationwide cross-sectional study with 21,841 non-institutionalized people ≥65 years old from the Spanish National Health Survey (2011/2012 and 2017) and the European Health Survey in Spain (2014 and 2020) was performed. We used descriptive statistics, performing two binary logistic regressions to determine the factors related to polypharmacy. The prevalence of polypharmacy was 23.2% (women: 28.1%, men: 17.2%; < 0.001). The most commonly consumed medicines were analgesics and tranquillizers, relaxants or sleeping pills in elderly women, compared with antihypertensives, antacids and antiulcer drugs and statins for elderly men. In both sexs, the positive predictors of polypharmacy included average, poor and very poor self-perceived states of health, people with overweight and obesity, being severely/non-severely limited due to a health problem, having ≥ three chronic conditions, visits to the family doctor and hospitalization. Among elderly women, negative predictors were alcohol intake, whereas in elderly men positive predictors were being 75-84 years old, being current smokers and having 1, 2 chronic conditions. Polypharmacy has a prevalence of 23.2%, with women accounting for 28.1% and men 17.2% of the total. Knowledge of positive and negative predictors of polypharmacy have important implications for public health efforts to develop or improve health guidelines and strategies for promoting the proper use of medication, particularly in the elderly population by sex.
很少有研究探讨非机构化老年人多重用药的流行病学中的性别差异。本研究旨在确定居住在西班牙的65岁及以上人群中多重用药的患病率,分析2011/12年至2020年期间该患病率的变化趋势,描述所涉药物的使用情况,并研究多重用药与某些社会人口学、健康相关变量之间的可能关系,以及按性别划分的护理服务使用情况。我们对来自西班牙国家健康调查(2011/2012年和2017年)以及西班牙欧洲健康调查(2014年和2020年)的21841名65岁及以上的非机构化人群进行了一项全国性横断面研究。我们使用描述性统计方法,进行了两项二元逻辑回归分析以确定与多重用药相关的因素。多重用药的患病率为23.2%(女性:28.1%,男性:17.2%;P<0.001)。老年女性最常使用的药物是镇痛药和镇静剂、松弛剂或安眠药,而老年男性则是抗高血压药、抗酸药和抗溃疡药以及他汀类药物。在两性中,多重用药的阳性预测因素包括自我感觉健康状况为一般、较差和非常差、超重和肥胖者、因健康问题而严重/非严重受限者、患有≥三种慢性病者、看家庭医生和住院。在老年女性中,阴性预测因素是饮酒,而在老年男性中,阳性预测因素是年龄在75 - 84岁、当前吸烟者以及患有1、2种慢性病。多重用药的患病率为23.2%,女性占总数的28.1%,男性占17.2%。了解多重用药的阳性和阴性预测因素对于制定或改进健康指南以及促进合理用药的策略的公共卫生努力具有重要意义,特别是在按性别划分的老年人群中。